Beyond Hyper-CVAD in ALL: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, PA-C
J Adv Pract Oncol 2022;13(suppl 1):9-11 |
© 2022 Harborside™
Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, discusses key data from a session on hyper-CVAD and additional therapies for patients with acute lymphoblastic leukemia presented by Elias Jabbour, MD, also of MD Anderson Cancer Center, at the 2021 SOHO Annual Meeting.
For access to the full length article, please sign in